CV Sciences Inc (OTCMKTS:CVSI) Communicates To Shareholders Through A Letter

CV Sciences Inc (OTCMKTS:CVSI) is pleased with its PlusCBD™ Oil brand and the way it has dominated the market. The company’s CEO, Joseph Dowling, today released a letter to the company’s shareholders in this regard. It was a week ago that the business guru unveiled its second quarter results. Dowling thanked all the stakeholders for the role they played to help the company report a high quarterly revenue. This was the highest peak since the company’s establishment. CV Sciences has achieved sequential revenue growth over14 consecutive quarters.

Dowling’s thoughts regarding the matter

Dowling attributes the consistent growth to the company’s product, the PlusCBD™ Oil brand. He adds that the company has also taken a notch higher its distribution activities, selling its wide range of products to more retail outlets. Every year, the company manages almost to double its retail outlets. That means higher sales of the product. CV Sciences continues enjoying increased selling opportunities.

The company’s CEO believes that the fundamentals that guide the company are appropriate. They are the reason they can serve the fast-expanding market for the hemp-based CBD products. The official applauds the company’s second quarter results and anticipates a brighter future.

Dowling and other leaders’ reservations and plans

However, the CEO expresses his dissatisfaction with certain aspects of the market reaction.

According to the official, the company has all along dedicated itself to giving timely quarterly updates. As a result, the company has been facing massive competition. Leaders in the company have expressed fears over a reduction in the quarterly revenues. They feel that something needs to be done to stop the choppy quarterly results that may be experienced over consecutive quarters.

The encouraging aspect is this company’s determination on not getting detracted at all. The company will continue taking advantage of the fast-growing market opportunities. It will also be hoping to expand its distributions activities further.

CV Sciences says it will continue investing in its brand to make it more accessible and also for profitability sake. The business giant says it will stop at nothing towards upholding the current growth trajectory. Strengthening the PlusCBD™ Oil brand remains the company’s topmost priority at the moment.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

CV Sciences Inc (OTCMKTS:CVSI) Posts A Drop Of 45% In Q1 2020 Results: E-Commerce Sales Surges By 24% And Accounts For 24% Of The Total Net Revenues USPTO Offers Notice Of Patent Allowance To CV Sciences Inc (OTCMKTS:CVSI) For Its Patent Application 15/426, 617: The Patent Allows Methods To Treat Smokeless Tobacco Addiction CV Sciences Inc (OTCMKTS:CVSI) To Move Into A Distribution Partnership With Kroger CV Sciences Inc. (OTCMKTS:CVSI) Record Q2 Revenue Strengthens Upward Momentum CV Sciences Inc (OTCMKTS:CVSI) Announces Its Financial Results For The First Quarter 2018

Pin It on Pinterest